Reversibility of sarcopenia by Ishige okamurae and its active derivative diphloroethohydroxycarmalol in female aging mice
article
OA: gold
CC0
Abstract
With the rapid increase in the elderly population worldwide, the number of people with sarcopenia has also increased significantly, and this disease is emerging as a medical and social issue. The development of pharmaceutics targeting sarcopenia is limited owing to the occurrence of side effects, and exercise therapy also has a limited scope of application. Therefore, it is necessary to develop safe and biocompatible agents to treat age-related sarcopenia. Ishige okamurae (IO), an edible brown alga, and its active substance, diphloroethohydroxycarmalol (DPHC), have been reported to have various physiological functions, including skeletal muscle regeneration ability. However, this effect has not been verified in an in vivo aging model. As an aging model, the oral IO extracts and DPHC supplemented 14-month-old female C57BL/6J mice were compared to the young group in this study; the mice model showed a substantial restoration of physical exercise ability with the imbalance of famine hormone and senescence-associated secretary phenotypes compared with those in young mice. Regarding the lean mass increase in aging mice following IO extract and DPHC administration, the muscular characteristics and molecular alterations in the gastrocnemius and soleus muscles, which are sensitive to the damage that occurs during the aging process, were significantly improved. Collectively, the current study reveals that the natural agent IO extract and its derivative DPHC can reverse sarcopenia that occurs during the process of aging by improving the imbalance of muscle regeneration in vivo.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (48)
- W1995707695 via openalex
- W1998867833 via openalex
- W2016562224 via openalex
- W2034013894 via openalex
- W2043221576 via openalex
- W2045709794 via openalex
- W2054506308 via openalex
- W2078186769 via openalex
- W2087071824 via openalex
- W2092189052 via openalex
- W2116629441 via openalex
- W2134461109 via openalex
- W2135817592 via openalex
- W2140407960 via openalex
- W2142647261 via openalex
- W2152200657 via openalex
- W2262653901 via openalex
- W2301977430 via openalex
- W2410004328 via openalex
- W2478127453 via openalex
- W2546015443 via openalex
- W2611701272 via openalex
- W2620955025 via openalex
- W2736416098 via openalex
- W2799723573 via openalex
- W2807039864 via openalex
- W2953709313 via openalex
- W2981890331 via openalex
- W2986417508 via openalex
- W3014503570 via openalex
- W3015764450 via openalex
- W3022107726 via openalex
- W3044198764 via openalex
- W3082582015 via openalex
- W3086116326 via openalex
- W3095782637 via openalex
- W3096019357 via openalex
- W3118085501 via openalex
- W3127074171 via openalex
- W3158481743 via openalex
- W3170817666 via openalex
- W3185578590 via openalex
- W3199714171 via openalex
- W3212843696 via openalex
- W4220985136 via openalex
- W6698128139 via openalex
- W6738962359 via openalex
- W6776504511 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK